Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

47 results about "Cerebrovascular Ischemia" patented technology

A disorder characterized by a decrease or absence of blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurological damage.

Herbicide composition and its preparation and application, medicament use

The invention discloses a traditional Chinese medicine combination, which is formed by raw medicines according to the proportion by weight as follows: ginseng or ginseng cauline leaf is 1 to 15 parts, and erigeron is 5 to 30 parts. Adopting the conventional traditional Chinese medicine combination formula, the invention has obvious neuroprotective effect and neural function improving, etc., by combining with the characteristics and advantages of the Chinese herb compound that are multi-component, multi-target, multi-level and multiple ways for treating complex disease; the invention can effectively block most pathological mechanisms of a plurality of disease nerve injury such as ischemic cerebrovascular disease, etc.; more particularly, for the improved aspect to the neurological symptom, the traditional Chinese medicine injection is helpful to enhance the living quality of a patient, and achieves the purpose of improving prognosis, and has important clinical application significance. The invention further discloses a preparation method of the traditional Chinese medicine combination and the pharmaceutical application.
Owner:重庆希尔安药业有限公司

Neuroprotective composition and uses thereof

InactiveUS20020128316A1Stabilizes cellular membranePromote normalizationBiocideNervous disorderDiseaseAntioxidant
A neuroprotective composition for protecting neuronal cells against oxidative stress and methods for using and preparing the same. More particularly, the neuroprotective composition of the invention comprises a mixture of pyruvate, antioxidant, and lipid(s) such as fatty acids. The neuroprotective composition could be used for the treatment of brain trauma, brain or cerebrovascular ischemia, neurodegenerative diseases, poisoning of neuronal cells, the diminution of drugs side effects and for preservation of neuronal grafts.
Owner:WARNER-LAMBERT CO

Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof

The invention discloses a traditional Chinese medicine composition for treating an ischemic cerebrovascular disease and application thereof in preparation of a medicament for preventing or treating the ischemic cerebrovascular disease, and belongs to the technical field of medicines. Aiming at the problem that a chemotherapeutic medicament for the ischemic cerebrovascular disease at present is large in hepatotoxicity, the traditional Chinese medicine composition for treating the ischemic cerebrovascular disease provided by the invention comprises the following components in parts by weight: 15 parts of scutellaria baicalensis, 6 parts of honeysuckle, 10 parts of pomegranate bark, 10 parts of shiny-leaved yellowhorn shell, 10 parts of mint, 20 parts of ramulus mori, 20 parts of root of red-rooted salvia, 10 parts of lotus leaves, 5 parts of ligusticum wallichii, 8 parts of large-leaved gentian, 15 parts of scorpio, 7 parts of burdock, 10 parts of root of kudzu vine and 10 parts of liquorice. The traditional Chinese medicine composition has a good treatment effect in the aspect of treatment of the ischemic cerebrovascular disease, and has significant clinical popularization value.
Owner:启东市丰武农副产品专业合作社

Ischemic cerebrovascular disease treatment composition, medicament, preparation method and application

The invention belongs to the pharmaceutical technical field, and discloses an ischemic cerebrovascular disease treatment composition, a medicament, a preparation method and application, the ischemic cerebrovascular disease treatment composition comprises ginsenoside Rg1 and astragaloside, and the weight ratio of ginsenoside Rg1 to astragaloside is 5:4. The animal pharmacodynamics experiments prove that the ischemic cerebrovascular disease treatment composition can inhibit the cerebral ischemia reperfusion injury of brain tissue, has the anti-cerebral ischemia-reperfusion injury enhancement effect by the astragaloside and ginsenoside Rg1 compatibility, also can improve energy metabolism disorders of the cerebral ischemia reperfusion injured brain tissue, anti-oxidative stress damage functions and the like, and ultimately achieves the purposes of enhancing the efficacy and reducing the toxic and side effects.
Owner:HUNAN UNIV OF CHINESE MEDICINE

Medicine for treating ischemic cerebrovascular diseases

The invention relates to a medicine for treating ischemic cerebrovascular diseases, which is prepared from eleven kinds of medicinal herbs including goldthread root, hooked uncaria, leeches and achyranthes and cyathula root. The invention also discloses the process for preparing the medicament.
Owner:周宇

Traditional Chinese medicine composition for nerve regeneration after cerebral arterial thrombosis and preparation method thereof

The invention belongs to the field of medicines, relates to a traditional Chinese medicine composition, and particularly relates to a traditional Chinese medicine composition for nerve regeneration after cerebral arterial thrombosis and application thereof in preparation of a medicament for preventing nerve regeneration after cerebral arterial thrombosis. Aiming at the problem of large hepatotoxicity of the traditional chemotherapeutic medicament for an ischemic cerebrovascular disease, the traditional Chinese medicine composition for nerve regeneration after cerebral arterial thrombosis provided by the invention comprises the following components in parts by weight: 15 parts of morinda officinalis, 6 parts of lindera aggregata, 10 parts of pericarpium granati, 10 parts of akebiaquinata, 10 parts of thunberg fritillary bulb, 20 parts of radix achyranthis bidentatae, 20 parts of salviae miltiorrhizae, 10 parts of sarcandra glabra, 5 parts of ligusticum wallichii, 8 parts of feather cockscomb seed, 15 parts of golden cypress, 7 parts of burdock, 10 parts of fructus cnidii and 10 parts of liquorice. The traditional Chinese medicine composition has a good treatment effect on the nerve regeneration after the cerebral arterial thrombosis, and has significant clinical popularization value.
Owner:杨献华

Caulis piperis kadsurae-caulis sargentodoxae-caulis sinomenii consciousness restoring composition, caulis piperis kadsurae-caulis sargentodoxae-caulis sinomenii medicinal preparation and application thereof

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a consciousness restoring medicine / composition, a caulis piperis kadsurae-caulis sargentodoxae-caulis sinomenii consciousness restoring medicinal preparation and application of the medicine or the preparation. A caulis piperis kadsurae-caulis sargentodoxae-caulis sinomenii brain arousing composition provided by the invention is characterized by being mainly prepared from caulis piperis kadsurae, caulis sargentodoxae and caulis sinomenii. The brain arousing medicine / composition and the caulis piperis kadsurae-caulis sargentodoxae-caulis sinomenii brain arousing medicinal preparation have the beneficial effects that the caulis piperis kadsurae, the caulis sargentodoxae and the caulis sinomenii, the functions of which are mainly wind dispelling, blood circulation promotion and collateral dredging, are combined together, are assisted by other medicines, and jointly have the effects of preventing and treating cerebrovascular ischemia and a nervous-system disease, resisting aging and preventing and treating diseases of diabetes, a fatigue syndrome, senile dementia and the like.
Owner:曹京敏

Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof

The invention discloses a traditional Chinese medicine composition for treating ischemic cerebrovascular disease and a preparation method thereof. The traditional Chinese medicine composition is mainly prepared from the following raw materials: angelica sinensis, radix codonopsis, prepared rehmannia root, glossy privet fruit, fructus psoraleae, radix puerariae, uncaria, white peony root, radix curcumae, Chinese yam, roasted rhizoma atractylodis macrocephalae and prepared radix licorice. The traditional Chinese medicine composition is used for treating the paracmastic ischemic cerebrovascular disease. The traditional Chinese medicine composition to which conventional auxiliaries can be added can be prepared into clinically acceptable tablets, granules, pills, capsules, dropping pills, sustained-release preparations and oral liquid preparations according to conventional process.
Owner:王政乾

Fuyuan Xingnao granule preparation and its preparation method and application

The invention relates to a recovery refreshing granular preparation and a preparation method and an application thereof. The recovery refreshing granular preparation is composed of the following raw medicinal materials: 200g of ginseng, 240g of leeches, 180g of prepared rhizoma arisaematis, 180g of rheum officinale and 300g of pseudo-ginseng. The preparation method comprises the following steps: performing reflux extraction on ginseng, prepared rhizoma arisaematis, rheum officinale and pseudo-ginseng with ethanol; after adding the leeches and rheum officinale into filter residues, decocting and extracting the filter residues with water; performing precipitation with ethanol; performing concentration to prepare a clear paste; and adding auxiliary materials into the concentrated clear paste to prepare the recovery refreshing granular preparation. An extraction process of the recovery refreshing formula clear paste is established and optimized, effective components in the recovery refreshing formula can be fully extracted to play roles of breaking blood and removing stasis, dispelling wind and removing stasis and consolidating constitution and tonifying qi, the curative effect on ischemic cerebrovascular disease is remarkable, and a formula meeting the requirement of the granular preparation is obtained.
Owner:上海市浦东新区浦南医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products